It has been 2 1/2 years since my son was diagnosed with CML. He was initially on Dasatinib, but switched to 400 mg Imatinib due to a liver enzyme issue. We just got his latest BCR/ABL results, and for the first time, he has had an increase. He has proven to be a turtle, and after 2 1/2 years, has not achieved MMR.
Apr 2022 - 50.6635%
Jul 2022 - 25.6086
Oct 2022 - 4.3022
Jan 2023 - 0.8209
Apr 2023 - 0.5972
Jul 2023 - 0.5200
Oct 2023- 0.4792
Jan 2024 - 0.3298
Apr 2024 - 0.2919
Jul 2024 - 0.2625
Oct 2024 - 0.3363
I take comfort in the fact that he has been below 1.0% since Jan 0f 2023. However, it seems he has plateaued and has now seen a rise. I am sure at his next meeting with the hematologist that there will be a discussion about either a dose increase or a switch of medication. Is changing dose or medication reasonable at this point, or should he continue to stay the course? I know that one rise is not a trend, so do we wait another 3 months to see what happens on his next test? I am admittedly more anxious about this than he is. He is young, and I know that the hematologist would like to see him get to that magic 0.1% much more quickly. However, I also know from others on this forum that bumps up and down are not unusual, and that even turtles can eventually get to MMR. Would appreciate some thoughts on this as we weigh his options. His adherence to the dosing schedule has been good and consistent.